Tag: Lumbosacral Radicular Pain Management Market Size

  • Lumbosacral Radicular Pain Industry Valued at $1.21 Billion by 2029 With CAGR of 5.8% | Size and Share Insights

    Lumbosacral Radicular Pain Industry Valued at $1.21 Billion by 2029 With CAGR of 5.8% | Size and Share Insights

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #What Is the Forecast for the Lumbosacral Radicular Pain Market from 2024 to 2025?#_x000D_

    The market for lumbosacral radicular pain treatments has seen robust growth in the past few years. The market is projected to expand from $0.91 billion in 2024 to $0.97 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. Factors such as the growing occurrence of lower back conditions, an increase in spinal problems in elderly individuals, the rise in sedentary lifestyles and poor posture, growing demand for pain alleviation treatments, and heightened awareness for early detection and intervention are driving this significant growth._x000D_

    _x000D_

    #What Is the Projected Market Size of the Lumbosacral Radicular Pain Market?#_x000D_

    The market for lumbosacral radicular pain is projected to experience significant expansion in the upcoming years, reaching a valuation of $1.21 billion by 2029, with a compound annual growth rate (CAGR) of 5.8%. This growth in the forecasted period is due to advancements in technologies for managing pain, an enhanced focus on non-opioid remedies, amplified investment in spinal R&D, increased demand for ambulatory and minimal intervention procedures, and broader healthcare access in developing markets. The forecast period also expects to see trends such as breakthroughs in minimally invasive surgical methods, the creation of targeted anti-inflammatory medication, ground-breaking wearable pain management devices, superior imaging for the identification of nerve roots, and the introduction of personalized treatment processes utilizing patient-specific information._x000D_

    _x000D_

    #Download The Free Sample Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp_x000D_

    _x000D_

    #Who are the Major Competitors in the Lumbosacral Radicular Pain Market Outlook?#_x000D_

    Major companies operating in the lumbosacral radicular pain market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Eli Lilly and Company, Boston Scientific Corporation, Vertex Pharmaceuticals, Biotronik, Nevro Corp., Sorrento Therapeutics, Scilex Holding Company, ProMed Pharma, SPR Therapeutics, Saluda Medical Pty Ltd., Eliem Therapeutics, Cephalon Inc., Semnur Pharmaceuticals Inc., Nalu Medical Inc., Sollis Therapeutics Inc._x000D_

    _x000D_

    #What Is Fueling Growth in the Lumbosacral Radicular Pain Market?#_x000D_

    The growth of the lumbosacral radicular pain market is anticipated to be driven by the rising occurrence of degenerative spinal conditions. Such conditions are a set of disorders stemming from the slow deterioration of the spine over time. The escalation in these spinal conditions is attributed to growing aging populations and lifestyle aspects that exacerbate the risk of spinal degeneration and nerve compression, thereby leading to increased demand for detection and treatment. Lumbosacral radicular pain plays a crucial role in spotting underlying degenerative spinal conditions by indicating nerve root inflammation or compression, which aids in clinical assessment and treatment. For example, forecasts from the University of Sydney, a public university based in Australia, in May 2023, suggest that over 800 million people globally will be dealing with back pain by 2050. Thus, the rising incidence of degenerative spinal conditions fuels the expansion of the lumbosacral radicular pain market._x000D_

    _x000D_

    #Request For A Customized Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=24591&type=smp_x000D_

    _x000D_

    #Which Lumbosacral Radicular Pain Market Segments Are Growing the Fastest?#_x000D_

    The lumbosacral radicular pain market covered in this report is segmented –_x000D_

    _x000D_

    1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures_x000D_

    2) By Route Of Administration: Oral, Topical, Injectable, Implantable_x000D_

    3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

    4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids_x000D_

    2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy_x000D_

    3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems_x000D_

    _x000D_

    #Which Industry Trends Are Shaping the Future of the Lumbosacral Radicular Pain Market?#_x000D_

    Critical players in the lumbosacral radicular pain market are making strides in the development of minimally invasive neuromodulation therapies, such as miniaturized and recharging spinal cord stimulation (SCS) systems, to provide improved pain management and patient comfort. These small, implantable spinal cord stimulators deliver electrical signals to the spinal cord to inhibit pain sensations, providing extended battery life and less invasive alternatives for treatment. For example, in December 2022, Abbott Laboratories, a U.S. health care company, introduced its Eterna spinal cord stimulation system to provide effective chronic pain relief using advanced BurstDR therapy. The system boasts an innovative rechargeable battery technology that substantially lengthens the interval between recharges, thus lessening patient inconvenience. Its unique stimulation patterns, specifically BurstDR, replicate natural nerve signals for more efficient and enduring pain alleviation. The design of this MRI-compatible device permits patients to receive full-body scans without the need for device extraction. The system’s design accommodates future enhancements, guaranteeing patients have access to future technological improvements without the necessity of further surgical procedures._x000D_

    _x000D_

    #Access The Full Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report_x000D_

    _x000D_

    #Which Countries Are Leading the Lumbosacral Radicular Pain Market?#_x000D_

    North America was the largest region in the lumbosacral radicular pain market in 2024. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #Purchase The Full Report Today:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24591_x000D_

    _x000D_

    #This Report Delivers Insight On: #_x000D_

    1. How big is the lumbosacral radicular pain market, and how is it changing globally?_x000D_

    2. Who are the major companies in the lumbosacral radicular pain market, and how are they performing?_x000D_

    3. What are the key opportunities and risks in the lumbosacral radicular pain market right now?_x000D_

    4. Which products or customer segments are growing the most in the lumbosacral radicular pain market?_x000D_

    5. What factors are helping or slowing down the growth of the lumbosacral radicular pain market?_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model